The Global Circulating Tumor Cells Market was valued at US$ 9.5 billion in 2023 and is projected to surpass the market size of US$ 19.0 billion by 2032 at a CAGR of 8.06% during the forecast period ...

For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone ...

A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical ...

The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

The non-invasive test, which measures circulating tumor cells in the blood, can predict treatment response, disease ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

In today’s Health Alert, new research shows that an easy blood test could help doctors decide on the best way to treat ...

Circulating tumor DNA is a promising tool for the detection and surveillance of HPV-positive oropharyngeal squamous cell ...

New ultrasound technique detects cancer biomarkers in blood, potentially replacing biopsies, with promising results for early ...